Budipine
Budipine is an anti-parkinson agent. Budipine also is a substrate of P-glycoprotein (P-gp), is mediated the uptake into the brain by P-gp. Budipine also is N-methyl-d-aspartate (NMDA) antagonist, and has indirect dopaminergic effects through an improved dopamine release, the inhibition of monoamine oxidase type B (MAO-B) . Budipine can be used for the research of CNS disorders include Parkinson disease[1].
Product Specifications
CAS Number
57982-78-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Budipine.html
Concentration
10mM
Purity
99.41
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CC(N1CCC(C2=CC=CC=C2)(C3=CC=CC=C3)CC1)(C)C
Molecular Formula
C21H27N
Molecular Weight
293.45
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
NMDA Receptor
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TAF2 (Transcription initiation Factor TFIID Subunit 2, TAF2 RNA Polymerase II, TATA box Binding Protein (TBP) -associated Factor, 150kD)
Recombinant Pig Lutropin-choriogonadotropic hormone receptor (LHCGR)